PD-L1 Biomarker Testing Market Is Expected to reach USD 1.46 Bn by 2032

The global PD-L1 biomarker testing market size was valued at US$ 541.6 Mn in 2021 and is expected to exhibit a CAGR of close to 9.4% over the forecast period (2022-2032).

Increasing incidence of cancer across the globe is underpinning the need for advanced cancer diagnosis equipment, which is expected to boost the market in the forthcoming years.  Cancer immunotherapy is emerging as a new avenue for the development of biomarker testing, thereby augmenting the growth in the market.

Rising technological advancements in immunotherapy are propelling the adoption PD-L1 biomarker testing for non-small cell lung cancer as an effective means for therapeutic usage of PD-L1 proteins for benign lesions or tumor identification.

Moreover, the unmet needs of cancer treatments are addressed by the growing availability of high-quality immunotherapy products worldwide. Lifestyle changes, such as physical inactivity, tobacco consumption and smoking, as well as unhealthy diet are prime factors responsible for the growing burden of cancerous indications in the current scenario.

The emergence of cancer immunotherapy has advanced the diagnostic approach to cancer detection and management, thus propelling the growth in the PD-L1 biomarker testing market.

Key players operating in the market space are focusing on the development or extension of novel biologics using existing biologic resources for innovative product identification and provision of patented therapies.

Furthermore, the occurrence of adverse conditions such as organ failure and relapse into cancer through the process of chemotherapy is anticipated to fuel the adoption of PD-L1 biomarker testing among major healthcare facilities worldwide.

“Growing advancements in the field of oncology, along with accurate prediction insights offered by automated systems for biomarker testing will boost the sales of PD-L1 biomarker testing in the forthcoming years” says an FMI analyst.  

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5897

Key Takeaways:

  • Based on product, PD-L1 22C3 assay kits segment is projected to account for over 53% of the market share by 2032, with sales increasing at a 10.2% CAGR over the forecast period.
  • In terms of indication, the NSCLS segment held 61.9% of the total market share in 2021, and the trend is expected to continue over the assessment period.
  • By end user, sales in the cancer research institutes segment accounted for 43.2% of the total market share in 2021.

North America is slated to be the largest leading region with a value share of over 61%, spearheaded by the U.S.

  • Sales in the U.K. will increase at a 10% CAGR over the assessment period.
  • China will emerge as a lucrative market, with demand growing at a 10.9% CAGR over the forecast period.

Competition Landscape

Leading players operating in the market are actively working in coherence with researchers to be able to acquire enhanced and innovative concepts to widen the therapeutic actions of the product. For instance:

  • In May 2020, F. Hoffman-La Roche AG acquired Stratos Genomics to develop DNA-based sequencing for diagnostic use.
  • In July 2020, Abcam plc. and Cancer Research UK partnered for the development and commercialization of novel antibodies to accelerate cancer research.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032. The global PD-L1 biomarker testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on PD-L1 biomarker testing market segment based on product (PD-L1 22C3 assay kit, PD-L1 28-8 assay kit, PD-L1 SP142 assay kit and PD-L1 263 assay kit), indication (NSCLS, melanoma, renal cell carcinoma, gastrointestinal tract malignancy, haematological malignancies, ovarian cancer and others), end user (hospitals, diagnostic laboratories and cancer research institutes) across seven major regions.

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-5897

Key Market Segments Covered In PD-L1 Biomarker Testing Industry Research

By Product:

  • PD-L1 22C3 Assay Kit
  • PD-L1 28-8 Assay Kit
  • PD-L1 SP142 Assay Kit
  • PD-L1 263 Assay Kit

By Indication:

  • NSCLS
  • Melanoma
  • Renal Cell Carcinoma
  • Gastrointestinal tract Malignancy
  • Haematological Malignancies
  • Ovarian Cancer
  • Other

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Cancer Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-5897

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Hormone Replacement Therapy Market is likely to grow at a CAGR of 11.29% through 2032

[340 Pages Report]  Hormone Replacement Therapy Market: Region wise Outlook
Depending on geographic regions, Global Hormone Replacement Therapy market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America is having more market for Hormone Replacement Therapy, In North America, U.S. represents the largest market because of increasing use of Hormone Replacement Therapy among patients aged 35 years and over.
The availability of compounded drugs i.e. drugs in varied strengths, dosage forms, etc – is a major factor, which tends to boost the revenue growth of this extremely popular treatment market. Early onset of aging coupled with rising disposable income levels are other important factors fuelling market revenue growth.Asia region is expected to have more growth rate in upcoming years because of increasing awareness about Hormone Replacement Therapy in this region. In Asia region India, China, Japan are expected to have more growth rate for Hormone Replacement Therapy.Hormone Replacement Therapy is any form of hormone therapy where in the patient, in course of medical treatment, receives hormones, either to supplement a lack of naturally occurring hormones, or to substitute other hormones for naturally occurring hormones.Menopause, is the time in most women’s lives when menstrual periods stop permanently, and the woman is no longer able to have children. Menopause typically occurs between 45 and 55 years of age. Medical professionals defined by a decrease in hormone production by the ovaries. In those who have had surgery to remove the uterus but still have ovaries, menopause generally occurs at the time of the surgery or when hormone levels fall. Following the removal of the uterus, symptoms typically occur earlier at the average of 45 years of age. 

Estrogen and progesterone are female hormones that play important roles in a woman’s body. Falling levels cause a range of physical and emotional symptoms, including hot flushes, mood swings and vaginal dryness. The aim of hormone replacement therapy is to restore female hormone levels, allowing the body to function normally again.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3871

Hormone Replacement Therapy Market: Drivers and Restraints

The prime drivers of hormone replacement therapy are increased demand from regenerative medicines such as anti-aging and reproductive-cycle boosting therapy such as menopausal hormone replacement. Rising demand in other therapeutic areas such as Growth Hormone Therapy and Thyroid Hormone Therapy due to comparatively safe profile, efficiency, and cost effectiveness of these drugs is expected to positively impact market growth. Moreover, new formulations such as transdermal drugs, gels and creams that offer benefits such as ease of drug administration and impact at location are expected to increase the growth of hormone replacement therapy market during the forecast period. Advantages associated with the hormone replacement therapy such as reduction in risk incidence of osteoporosis, cardiovascular disease, and reduction of vasomotor symptoms are also expected to boost the growth of hormone replacement therapy market in the coming years.

Hormone Replacement Therapy has side effects such as fluid retention, headache, indigestion, and depression. These are anticipated to hamper the popularity of the therapeutic area. Furthermore, UK-based NICE notes that hormone replacement therapy could be associated with breast cancer risk if the drugs oestrogen and progesterone are taken in combination. Prolonged consumption of HRT drugs could also lead to increased risk of blood clots. Studies have estimated that for every 1,000 women taking HRT tablets for 7.5 years, less than two will develop a blood clot. These restraints seem quite negligible when compared with the benefits of HRT.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3871

Hormone Replacement Therapy Market: Key Players

Some of the key market players in Global Hormone Replacement Therapy market are Bayer AG, Pfizer, Merck & co., BioSante Pharmaceuticals and Amgen, QuatRx Pharmaceuticals, Noven Pharmaceuticals.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Pipeline Assessment
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil and Rest of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
  • Eastern Europe (Poland, Russia and Rest of Eastern Europe)
  • Asia Pacific without Japan (China, India, ASEAN, Australia & New Zealand, Rest of Asia Pacific without Japan)
  • Japan
  • Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/3871
Hormone Replacement Therapy Market: Segmentation 

Based on Therapy Type,

  • Estrogen Replacement Therapy
  • Growth Hormone Replacement
  • Dopamine Agonist
  • Somatostatin Analogues
  • Thyroid Hormone Replacement
  • Tablets
  • Capsules
  • Injections

Based on Application

  • Cancer
  • Menopause
  • Hypopituitarism
  • Hypothyroidism
  • Others

Based on Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies and Drugstores
  • Compounding Pharmacies
  • E-commerce
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Animal Model Market is projected to reach US$ 2.4 Bn by 2028, registering a healthy CAGR of 6.6% from 2022 to 2028

[170 Pages Report] According to a recently compiled study by Future Market Insights, the global animal model market will reflect an impressive CAGR through the forecast period, 2017 to 2026. Revenues from the global market for animal model are poised to surpass US$ 2,200 Mn by 2026-end.

Leveraging Animal Models offers Better Understanding of Different Diseases

Animals and human beings share a common biological as well as physiological structure. Animals possess shorter life cycle, however they have high genotype resemblance. It is simple and easy to control the animal environment as compared to the human beings.The animal models are increasingly being used in the biomedical research that helps to develop new treatment methods for various diseases. Leveraging animal models offers a better understanding of different diseases, along with the efficacy of drugs with regard to the diseases.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3141

Owing to these factors, demand for animal models has been witnessing a significant surge in the healthcare sector. Alternatives such as cell cultures, tissue cultures, and computer models are also available, however animal models are more preferred owing to the complexity of the living systems. This further makes animal models an effective choice for biomedical research.

Development of animal models, which are more predictive in being effective is an iterative process. However, progress is being made, with researchers applying new experimental approaches to elucidate the biology of specific diseases for the creating of new and efficient animal models.

During the development of new drugs dedicated to complex diseases, researchers are being well advised for testing drugs in multiple animal models as well as in mouse strains with different genetic backgrounds.

Researchers are also focusing on employing translational efficacy or pharmacodynamic biomarkers for linking efficacy observed in clinical results with pre-clinical analyses.

animal model market

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-3141

Key Takeaways from FMI’s Report on Global Animal Model Market

  • North America is expected to remain the largest and fastest expanding market for animal model, with revenues estimated to surpass US$ 800 Mn by 2026-end. Between animal model markets in Asia-Pacific and Europe, the former will account for relatively larger revenue share, whereas the latter will expand at a comparatively higher CAGR through 2026. Although the market in South Korea will account for the lowest market revenue share, revenues are projected to expand at a relatively higher CAGR than those from the markets in Latin America and Middle East & Africa (MEA) through 2026.
  • On the basis of species, revenues from rats and mice are projected to account for over two-fifth share of the market by 2026-end. Revenues from use of rats in animal models will expand at the highest CAGR in the market through 2026. In addition, revenues from use of cats and monkeys in animal models will rise at a nearly equal CAGR through 2026. Dogs and pigs are expected to remain the least lucrative species used in animal models during the forecast period.
  • Contract research organizations (CROs) and biotechnology companies are anticipated to remain the fast expanding end-users of animal models. Revenues from these two end-users are collectively forecast to surpass US$ 850 Mn by 2026-end. In terms of revenues, academic & research institutions and pharmaceutical companies will continue to be dominant end-users in the global animal model market.
  • Basic and applied research application of animal model will continue to register the fastest expansion through 2026. However, drug discovery/development will remain the most lucrative application of animal model.
  • Key companies actively contributing to growth of the global animal model market include Transposagen Biopharmaceuticals, Inc., Envigo CRS SA, Crown Bioscience, Inc., Eurofins Scientific SE, Genoway SA, Taconic Biosciences, Inc., Trans Genic Inc, The Jackson Laboratory, Horizon Discovery Group plc, and Charles River Laboratories International, Inc.

Key Segments of Animal Model Industry ResearchAnimal Model Market by Species:

  • Rats
  • Mice
  • Guinea Pigs
  • Rabbits
  • Monkeys
  • Dogs
  • Pigs
  • Cats
  • Other Species

Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-3141

Animal Model Market by End User:

  • Academic & Research Institutions
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Other End Users

Animal Model Market by Application:

  • Basic and Applied Research
  • Drug Discovery/Development

Animal Model Market by Region:

  • North America Animal Model Market
  • Latin America Animal Model Market
  • Europe Animal Model Market
  • East Asia Animal Model Market
  • South Asia & Pacific Animal Model Market
  • Middle East & Africa (MEA) Animal Model Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Micro Inverter Market is reaching US$ 4.36 Bn by 2032 | FMI

With an estimated CAGR of 9.6% during the projected period, the micro inverter market share is expected to reach US$ 4.36 Billion by 2032 from US$ 1.55 Bn in 2021, finds a recent report published by FMI. Furthermore, the study finds that the rising demand for solar micro inverters technology proportionately reflects the adoption of micro inverters in emerging nations.

Micro-inverters provide several technological benefits over other types of solar micro inverter, such as string and central, unlike conventional inverters, which are installed separately from the solar array. These micro-grid-tie inverters are capable of operating and monitoring multiple solar panels simultaneously. In addition, micro inverters are installed beneath each solar panel and regular power flow even when one or more of their panels are shaded; this has improved micro inverter appeal among end-users.

As a result, micro inverters are frequently used in conjunction with solar panels. COVID-19 has influenced not just the business sector but also the entire economy. Economic activity is projected to continue to decline due to a growing number of nations implementing and prolonging lockdowns, which will have a negative influence on the global economy.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14322

Additionally, COVID-19 is likely to negatively influence the micro-inverter industry because of the drop in demand for electricity from commercial applications. Power generation has been curtailed in nations affected by COVID-19 due to lockdowns. This is because business end-user demand for electricity has decreased in these nations.

While home power demand has grown due to lockdowns, business and industrial end-users continue to consume the majority of electricity. In addition, due to the ongoing epidemic, some solar facilities in these nations have suspended energy production, which is projected to diminish the demand for micro inverters over the next several years.

“The major firms are focused on sustaining product quality to considerably grow their competitive market share. Significant players in North America, APAC, and Europe are focusing their efforts on reducing hazardous emissions through product development. Globally, major micro inverter manufacturers are increasingly pursuing strategic collaborations, joint ventures, acquisitions, and partnerships to maintain a competitive edge in the market.”—opines an FMI analyst.

Key Takeaways:

  • Microinverter systems are mostly used in homes and businesses. Although end users lack the competence to put microinverters into solar panels, system integrators or third-party suppliers are usually hired.
  • The indirect sales channel segment is likely to dominate the micro inverter market. Residential application is predicted to increase at the fastest rate. Increasing energy costs and supporting government regulations globally have led to increased energy-saving solutions for residential applications.
  • The APAC solar micro inverters market is growing due to rising demand from key nations, including Japan, Australia, India, and China. In addition, emerging markets like China and India dominate APAC. Increasing commercial solar PV systems for industrial, residential, and other applications is pushing the APAC micro inverter market.

Competitive Landscape

Micro inverter players have strengthened their offers in the market through various organic and inorganic growth tactics, including product development, partnerships, agreements, and collaborations.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14322

Among the key players are Enphase Energy (the United States), Altenergy Power System (the United States), Darfon Electronics (Taiwan), ReneSola (China), AEconversion (Germany), and Silicon Power (the United States). The research offers a comprehensive competition analysis of these micro inverter market leaders, including their company profiles, recent developments, and important market strategies.

  • Enphase Energy announced a partnership with Excel Power of Australia in June 2020. Excel Power built a 50 kW Enphase micro inverter system for Wippells Autos, a Jaguar and Land Rover dealership in Toowoomba City, Queensland, as part of this agreement (Australia).
  • Enphase Energy partnered with Teslandi.pro of the Netherlands on a commercial initiative in January 2020. Island. pro’s commercial solar division was picked by E-Unit, a sustainable building developer, to install a 780 kW solar energy system on its new 42-unit building in Arnhem (Netherlands). This commercial solar installation has 2,600 Enphase IQ 7+ micro inverters.
  • Envertech launched EnverView 2.0, an improved version of their smart monitoring program, in February 2019 for both the iOS App Store and the Android Play Store. This new version includes increased operating capabilities and user interfaces over the previous version.

About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

Pharmaceutical Lipids Market is expected to reach US$ 7.70 Bn by the end of 2032, with sales increasing at a 5.1% CAGR.

Global pharmaceutical lipids market is projected to rise at a considerable pace between 2021 and 2031, finds Future Market Insights in an in-depth study. Growth registered in the market is attributable to increasing cases of cholesterol abnormalities and lipid associated disorders. Lipids are generally utilized in industries such as cosmetics and personal care, beverage and food, and pharmaceutical. Rising urbanization that has led to remarkable lifestyle changes have been influencing trends in the cosmetics and personal care industry. Expansion of the sector, which also is a key end user, will fuel sales of pharmaceutical lipids.

Social media and digitalization are greatly influencing the sales of beauty care products. Coupled with this, increasing demand for the effective and fast-acting medications combined with improvement of advance drug manufacturing facilities have been driving the pharmaceutical lipids market. Also, the rising incidence of cancer, neurological diseases, cardiovascular diseases, and other chronic diseases are expected to fuel the demand for pharmaceutical lipids

According to the report, demand in the triglycerides segment within the market will be considerably high. It is expected to account for nearly 44% of the market in 2021.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-10983

Key Takeaways from Pharmaceutical Lipids Market Study

  • The global pharmaceutical lipids market will rise at 5.2% CAGR between 2021 and 2031
  • The U.S. is the most lucrative market in the global pharmaceutical lipids market and is expected to grow with a CAGR of 5.5% between 2021-2031
  • The demand for triglycerides will continue rising in the U.K., driving pharmaceutical lipids sales
  • Germany will lead the Europe market; France too will continue exhibiting high demand
  • China will account for maximum sales in East Asia

“The rising demand for advanced rapid drug delivery technologies, increasing adoption of natural care products, and rising geriatric population will continue fuelling the demand for growth of pharmaceutical lipids” says the FMI Analyst.

Who is Winning?

Companies operating in the market are looking for strengthening their footprint via strategic tie-ups and acquisitions. The pattern is primarily seen across companies operating in Europe and North America.

For instance:

  • In, July 2020, ABITEC Corporation announced that it has acquired Larodan AB, a manufacturer and international marketer of state of the art, high-purity research grade lipids.  This strategic acquisition will expand ABITEC’s functional lipid product offerings and scientific capabilities to better serve the pharmaceutical, nutritional and industrial market sectors.
  • In September, 2019 BASF acquired aroma biotech innovation leader isobionices to increase its product portfolio for F&F ingredients.

Key Participant Insights

The pharmaceutical lipids market is considered to be an exceptionally competitive market. The strategies involve growing new lipid-based formulations. Research is being led in regards to designing combination drugs (proteins and lipids) for projection with respect to dyslipidemia and furthermore cardiovascular disorders. This pattern is relied upon to make a significant rise in the estimated time frame. The key market players covered by FMI include ABITEC Corporation (ABF Ingredients), NOF (Nippon Oil & Fats) Corporation, Lipoid GmbH, Nippon Fine Chemical Co. Ltd., BASF SE, Dishman Group, Cayman Chemical Company, CordenPharma, Croda International Plc, Gattefossé, IOI Oleo GmbH, Merck KGaA, Stepan Company and Evonik Industries AG.

Pharmaceutical Lipids Market by Category

By Product Type:

  • Triglycerides
  • Phospholipids
  • Sphingolipids
  • Cholesterol
  • Fatty Acids
  • Others

By Form:

  • Liquid Pharmaceutical Lipids
  • Semi-solid Pharmaceutical Lipids
  • Solid Pharmaceutical Lipids

By Source:

  • Synthetic Pharmaceutical Lipids
  • Semi-synthetic Pharmaceutical Lipids
  • Natural Pharmaceutical Lipids

By Application:

  • Conventional Lipid-based Drug Delivery Systems
  • Self-Emulsifying Drug Delivery Systems
  • Self-Microemulsifying Drug Delivery Systems
  • Liposomes
  • Solid Lipid Nanoparticles
  • Nanostructured Lipid Carriers
  • Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-10983

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Sustainable Aviation Fuel Market is Expected to Reach US$ 15 Billion, with a CAGR of 60% From 2022 to 2032 | FMI

The sustainable aviation fuel market was worth US$ 220 Mn in 2021 and is expected to reach US$ 15 Bn by 2030, with a CAGR of 60% from 2022 to 2032.

The COVID-19 virus has spread across the globe without regard for national boundaries. As a result, it has had a severe economic and financial impact on all industries, sectors, and facets of life, as well as tremendous uncertainty.

Governments all over the world are canceling visas for foreign residents and closing down damaged areas, which is one of the principal factors for the aviation industry’s downturn.

The aviation industry is dedicated to lowering carbon emissions to create a more sustainable environment and comply with stringent emission laws. As a result, sustainable alternative fuels are being adopted by various participants in sustainable aviation fuel companies, such as improving aero-engine efficiency through design changes, hybrid-electric and all-electric aircraft, renewable jet fuels, sustainable aircraft fuel, and so on.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14269

Most military aircraft and commercial airlines use sustainable aviation fuel to enhance fuel efficiency and decrease operational costs.

The sustainable aviation fuel market has grown significantly over the years, owing to the growing trend of advanced fuels being employed in aircraft all over the world.

The sustainable aviation fuel market trends such as an increase in the number of airline passengers combined with an increase in disposable income, an increase in air travel, and an increase in synthetic lubricant use all contribute to the worldwide sustainable aviation fuel market growth. However, oscillations in crude oil prices and lubricant contamination are anticipated to hamper sustainable aviation fuel market growth during the forecast period.

Furthermore, the developments of environmentally friendly and safe renewable jet fuel and the rise in demand for low-density lubricants to reduce weight are likely to provide various chances for market expansion throughout the forecast period.

In terms of revenue, North America leads the market, followed by Europe, Asia-Pacific, and LAMEA. In 2020, the United States will dominate the sustainable aviation fuel market. Due to an increase in demand for sustainable aviation fuel across the country, Mexico is predicted to grow at a high rate during the forecast period.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14269

Sustainable aviation fuel offers airlines a chance to invest in the future. The predicted growth in demand for sustainable aviation fuel is unlikely to be reached unless airline operators boost their renewable aviation fuel obligations with bio-refineries, resulting in fuel cost and availability benefits.

With the predicted rise in the adoption of sustainable aviation fuel on a global scale, airport infrastructure investments are anticipated to grow.

Key Segments

By Platform:

  • Commercial Aviation
  • Military Aviation
  • Business & General Aviation
  • Unmanned Aerial Vehicle

By Biofuel Blending Capacity:

  • Below 30%
  • 30% to 50%
  • Above 50%

By Type:

  • Total Stations
  • Global Navigation Satellite Systems (GNSS)
  • Laser Scanners
  • Sensors
  • Others

By Biofuel Manufacturing Technology:

  • Hydroprocessed Fatty Acid Esters and Fatty Acids – Synthetic Paraffinic Kerosene (HEFA-
  • Fischer Tropsch Synthetic Paraffinic Kerosene (FT-SPK)
  • Synthetic Iso-paraffin from Fermented Hydroprocessed Sugar (HFS-SIP)
  • Alcohol to Jet SPK (ATJ-SPK)
  • Catalytic Hydrothermolysis Jet (CHJ)

By Fuel Type:

  • Biofuel
  • Hydrogen Fuel
  • Power to Liquid Fuel
  • Gas-to-Liquid

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Japan
  • Western Europe
  • Eastern Europe
  • Middle East & Africa

About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

3D Printed Medical Devices Market is set to experience a significant growth rate of 16.1% CAGR from 2022 to 2028

[212 Pages Report] Currently heading towards a market value of over US$ 440 Mn, the global market for 3D printed medical devices is projected for stupendous growth at 16% CAGR during 2022- 2029. North America will remain the leading market for 3D printed medical device sales, whereas the market attractiveness of Asia Pacific has been rising notably.

The market growth is primarily assisted by advancements in 3D printing technology, surging government spending in healthcare sector, increasing usage of 3D printed medical devices for medical procedures, and relative simplification of the manufacturing process of 3D printed medical devices. Introduction of Computer-aided Design (CAD) for 3D printing can create trail ready devices, thereby reducing manufacturing time, time to market as well as operational cost.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1501

Key Takeaways – 3D Printed Medical Devices Market Study

  • Although metals and alloys are most preferably used for 3D printed medical devices, biomaterial inks are expected to gain traction during the forecast period owing to their highly biocompatible and versatile physical properties.
  • PolyJet – InkJet 3D printing technology currently holds maximum share of 3D printed medical devices market. However, consistent development and adoption of innovative technologies may reduce the 3D printed medical devices market share of this technology during the forecast period.
  • Use of 3D printing technology in orthopedic implants is shaping the future of 3D printed medical devices market. It currently accounts for nearly half of the market value.
  • The consistently expanding patient pool and growing preference for personalized implants in joint replacement surgeries will remain key boosters to growth of 3D printed medical devices demand in orthopedics.

Asia Pacific has become the global hub of opportunities, and the leaders in 3D printed medical devices landscape have been eying the opportunity here – owing to the massive application scope, remarkably growing patient population, and relatively less manufacturing costs.

Who Is Winning?

Until late 2016, the key focus of most leading players in the 3D printed medical devices market was geographic expansion through acquisition and merger. In May 2016, Johnson & Johnson announced collaboration with a subsidiary of HP Inc. for manufacturing personalized healthcare solutions at reduced costs through 3D printing techniques. J&J collaborated with Organovo to carry out feasibility study on bio printed human tissue for testing new medications to work with Carbon 3D, famous for ultra-fast Continuous Liquid Interface Production (CLIP) technology for production of custom surgical devices.

The focuse is now gradually shifting towards expansion through strategic partnerships to improve their distribution network. For instance, in 2017, Envision partnered with ScanSource, Inc. to deliver 3D printing solutions to resellers in the Americas. Similarly, in 2018, 3D Systems and Stryker announced distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for carniomaxillofacial specialty.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1501

Learn More About Report Inclusions

Future market insights offers a unique perspective and actionable insights on 3D printed medical devices market in its latest study, presenting historical demand assessment from 2014 – 2021 and projections from 2022 – 2029 based on application (orthopedic implants, dental implants, carnio-maxillofacial Implant), material type (metals and alloys, biomaterial inks and plastics) technology (stereolithography (SLA) – liquid-based 3D printing, selective layer sintering (SLS) – powder-based 3d printing, digital light processing(DLP), fused deposition modelling (FDM)-plastic filament extrusion-based, polyjet – inkjet 3D printing, electronic beam melting (EBM) ) end user (hospitals, ambulatory surgical centers, diagnostic centers) in seven key regions.

Key Market Segments Covered in 3D Printed Medical Devices Industry Research By Application :

  • Orthopaedic Implants
  • Dental Implants
  • Cranio-maxillofacial Implants
  • Internal and External Prostheses

By Technology :

  • Stereolithography (SLA) – Liquid Based 3D Printing
  • Selective Layer Sintering (SLS) – Powder Based 3D Printing
  • Digital Light Processing(DLP)
  • Fused Deposition Modeling (FDM): Plastic Filament Extrusion Based
  • PolyJet / InkJet 3D Printing
  • Electronic Beam Melting (EBM)

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1501

By Distribution Channel :

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Material :

  • Plastics
    • Thermoplastics
    • Photopolymers
  • Biomaterial Inks
    • Polymers
    • Ceramics
    • Hydrogels
  • Metals and Alloys

Subsea Multiphase Flowmeter Market with Potential Impact, Despite COVID-19 Pandemic, Finds FMI

Substantial increase in the focus on developing integrated flow metering solutions with automation and digitalization technologies, suitable for various applications are expected to drive the global subsea multiphase flowmeter market. As per Future Market Insights (FMI), the global subsea multiphase flowmeter market is projected to be valued at ~US$ 616.6 Mn in 2021.

The ongoing COVID-19 crisis has caused severe impact on the global economy. It has resulted in partial to complete shutdown of the supply chain networks and manufacturing activities across certain regions. Subsequently affected the subsea multiphase flowmeter market, adversely affecting growth. However, subsea multiphase flowmeter market is expected to recover sharply as the economic activity resumes post the containment of pandemic.

The production measurement segment is gaining prominence owing to its functionality of measuring the inflow and outflow of oil & gas such. Moreover, in the near future, it is expected that the scope of production measurement can be extended to enhancing inflow profiling in deepwater reserves, which will further augment demand for subsea multiphase flowmeter.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11893

Key Takeaways of Subsea Multiphase Flowmeter Market Study

  • Subsea flowmeter market is expected to register 8.5% CAGR between 2021 and 2031
  • The U.S. is expected to have highest market share the global subsea multiphase flowmeter market. Within North America, it is expected to account for over 66% of sales
  • The U.K. will emerge as a key market within Europe, exhibiting 5.6% y-o-y growth in 2021
  • Expansion of oil and gas production will continue supporting growth in Germany and France
  • China will continue driving sales in East Asia, backed by rising demand for energy

“Key industry participants are investing in strategic alliances, partnerships and product innovations to gain a competitive advantage in the evolving global market. These partnerships allow companies to improve their production capacity and strengthen their technical expertise.” says Future Market Insights analyst.

The subsea multiphase flowmeter market is gradually growing at a strong trend in due to increasing integration of technologies with automation and digitalization in subsea multiphase flowmeters for challenging flow metering solutions for regular production monitoring and measurement. Rise in oil and gas investments and increase in oil and gas projects provide extensive opportunities for the subsea multiphase flowmeter market.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-11893

Competitive Landscape

The subsea multiphase flowmeter market witness moderate consolidation, in which the leading players account for more than 70% of the market share. The penetration of small regional players makes this market more competitive. Some of the key players in the market are Weatherford, Baker Hughes, AMETEK Inc., Schlumberger Limited, ABB Ltd, TechnipFMC PLC, Emerson, KROHNE Japan KK, Peitro Fiorentini S.p.a., Haimo Technologies Group Corp., and Tokico System Solutions Ltd among others. These players have higher shares in the global market, and have longstanding relationships with a number of end users, giving them an upper hand among their peers.

Find More Valuable Insights

The research report analyzes the market demand trends of subsea multiphase flowmeter. The global market estimation and growth projection is based on factors like end use industries development, COVID-19 crisis impact, replacement ratio, and adoption rate of subsea multiphase flowmeter. As per Future Market Insights research scope, the subsea multiphase flowmeter market has been studied and segmented on the basis of pipe size, application, construction material and region. The report provides qualitative and quantitative information on various players in this market. This report also tracks the market by both, supply side and demand side.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-11893

Subsea Multiphase Flowmeter Market by Category

By Pipe Size

  • 2″ Subsea Multiphase Flowmeter
  • 3″ Subsea Multiphase Flowmeter
  • 4″ Subsea Multiphase Flowmeter
  • 6″ Subsea Multiphase Flowmeter
  • 8″ Subsea Multiphase Flowmeter
  • 10″ Subsea Multiphase Flowmeter

By Application

  • Subsea Well Testing
  • Production Monitoring
  • Production Measurement
  • Others

By Construction Material

  • Stainless Steel Subsea Multiphase Flowmeter
  • Duplex Steel Subsea Multiphase Flowmeter
  • Corrosion Resistant Alloys Subsea Multiphase Flowmeter
  • Titanium Subsea Multiphase Flowmeter
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East and Africa (MEA)

About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

Vascular Patches Market is expected to reach $254 Mn by 2032 | FMI

Vascular patches are the microporous patch of bio-compatible polyester-urethane patches which are used for vascular surgeries for suturing closure. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of deaths, claiming approximately 17.9 million lives every year.Vascular patches are highly biocompatible, minimally infectious, low suture line bleeding by its highly elastic material and excellent incorporation of tissue and doesn’t require impregnation or pre-clotting and favorable handling properties.

The global vascular patches market is expected to grow lucratively in coming years, due to the high prevalence of cardiac complications, technological and healthcare increments. Coronavirus has negatively impacted the vascular patches market by drawing global attention towards the massive influx of the coronavirus patients, which ultimately shifted the medical, research attentions and investments towards it from the other disease areas.

Also, the lockdown imposed during the pandemic outbreak resulted in the shutdown of labs, offices, halted supplies and restricted the regular visits of patients of other diseases such as cardiac diseases.

Increasing prevalence of cardiac diseases driven by the sedentary lifestyle, stress and other disruptive habits, and the surging medical advancements, high adoption rate of vascular patches due to their excellent biocompatibility, and awareness are driving the growth of vascular patch market.

The rising cases of ischemia stroke, expanding geriatric populations are transcending the needs for stenosis and surgeries of autologous vessels including saphenous vein and internal thoracic artery. The advanced surgical technologies, major players with their deliberated research to develop novel vascular patches.

The rising awareness of cardiac diseases, surgeries and escalating healthcare infrastructures are also fueling the market. However, the growth is restrained by the dwindling numbers of surgeries, products failure and recalls, and associated risk of hematomas, severe bleeding and death.

Although, the overall growth of the vascular patches market is expected to leverage with the advancing medical technologies and excellent vascular patches materials, expanding patient population and awareness.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12868

The global vascular patches market is expected to escalate in coming years with its increasing adoption rate to treat cardiac complications, the medical advancements and availability of biocompatible vascular patches. By material, biological vascular patches lead the market with its high adoption rate due to the excellent biocompatibility, low risk of infections, safety and easy usage.

By application, carotid endarterectomy (CEA) rules the segment due to the elevated numbers of surgeries performed every year to prevent strokes and has high efficacy. By end-user, the hospital holds the largest share due to the highly sophisticated healthcare infrastructure, well experienced medical professionals and advanced patient care and surgeries.

The global vascular patches market is anticipated to be dominated by North America due to the huge geriatric population, surging cases prevalence of cardiac complications, advanced R&D and technology and awareness. Europe is expected to hold the second-largest vascular patches market with its diverse vascular patch products, high healthcare expenditure and infrastructure.

Asia-Pacific vascular patches market is expected to emerge as the fastest-growing market, driven by the escalating healthcare infrastructure, research, medical technologies, growing awareness, and giant patient pool.

Latin America vascular patches market is also expected to grow with the research and innovations of vascular and endovascular surgeries. Middle East &Africa vascular patches market are expected to elevate gradually with the progressing healthcare infrastructure.

The key players of vascular patches market include

  • B. Braun Melsungen AG
  • BD
  • LeMaitre
  • Baxter International
  • Getinge AB
  • VUP Medical
  • McKesson Medical-Surgical Inc.
  • CryoLife, Inc.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Historical Actual Market Size, 2015 – 2019
  • Market Size & Forecast 2020 to 2030
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12868

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance
Key Segments

The global vascular patches market is segmented into material, application, end-user and region.

By material :

  • Biologic vascular patch
  • Synthetic vascular patch

By application:

  • Carotid endarterectomy (CEA)
  • Abdominal aortic aneurysms (AAA)
  • Coronary Artery Bypass Grafting (CABG)
  • Profundaplasty
  • Others

By end-user:

  • Hospital

Ambulatory surgical centres

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Bacteriophage Market is projected to register 4.2% CAGR and top a valuation of US 67.72 Mn by the end of 2031 | FMI

[266 Pages Report] The global demand for bacteriophages market is expected to grow at a 4.2% CAGR from 2021 to 2031, reaching a valuation of US$ 41.46 Mn in 2021. According to the study, the oral route of administration segment held a significant share of around 97% of the global market in 2021.

Rising demand of phage probiotics due to its several advantages over traditional probiotics is propelling the growth in the market. Phage probiotics stimulate growth of good gut bacteria over bad gut bacteria and help maintain a healthy gut.

Additionally, growing development of new treatment options for anti-bacterial resistant infections is improving the growth in the market. Rising awareness regarding the use of bacteriophage probiotics for patients with bowel difficulties, immune mediated digestive issues will also boost the market.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14461

Surging demand for phage probiotics has encouraged the key players in the market to up their game by increasing investment in research and development (R&D) for new bacteriophages. In comparison to antibiotics, bacteriophages possess high host specificity, they exhibit good benefits with single hit kinetics, are self-replicating and also possess anti-biofilm properties.

As per FMI, gastroenterology is the most sought after application of phage probiotics, as phage probiotics are administered by doctors since phage therapeutics do not get early clearance from regulatory authorities in many developing regions.

Bacteriophage probiotics are mostly administered via the oral route since it is non- invasive, shows immediate release and is cost effective. These probiotics are widely available in retail pharmacies, thereby, boosting the sales in developing nations.

Key Takeaways from Market Study

  • Phage probiotics are expected to hold over 95% market value share in 2021, and are expected to display a CAGR growth of 4.2% over the forecast period.
  • The oral route of administration accounted for over 96% of market share in 2021 and is expected to hold a market share by value of 97.2% by 2031.
  • In terms of application, gastroenterology registered growth at a CAGR of 4.3% in 2021, with a market share of 93.8%.
  • Retail pharmacies will hold a higher share in the bacteriophage market due to presence of large chain of retail pharmacies and easy availability of pharma products
  • Europe is slated to be the largest leading region with a value share of 43% by the end of the forecast period due to presence of large healthcare infrastructure and strong R&D centers.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-14461

 “With rising prevalence of antibacterial resistance, the bacteriophage market is expected to witness steady growth over the forecast period. To curb the global burden, key players are likely to invest extensively in R&D activities to develop effective phage probiotics” says an analyst of Future Market Insights.

Market Competition

Acquisitions, expansion, development of an extensive product pipeline and product launches are the key strategies adopted by manufacturers to increase their revenue and expand their consumer base in different geographies.

  • In August 2021, Carillon Miami Wellness Resort partnered with the biostation to launch a new functional medicine practice located at the resort’s award-winning, 70,000-square-foot spa and wellness facility.
  • In February 2020, Microgen’s Bacteriophage products have been included into clinical recommendations for urology.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global bacteriophage market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on bacteriophage market segment based on product – (phage probiotics, phage therapeutics), by route of administration- (oral, topical, others), by application (gastroenterology, respiratory infections treatment, skin infection treatment, wound prophylaxis, urogenital infection treatment, others), by distribution channel (retail pharmacies, hospital pharmacies, online pharmacies) and across seven major regions.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/14461

Key Players:

  • Life extension
  • Arthur Andrew Medical
  • Deerland Probiotics & Enzymes Inc.
  • BioChimpharm
  • Micreos Human Health
  • Designs for Health
  • Accelerated Health Systems LLC
  • The biostation
  • Microgen
  • IntraLytix Inc.

Key Market Segments Covered In Bacteriophage Industry Research

By Product:

  • Phage Probiotics
  • Phage Therapeutics

By Route of Administration:

  • Oral
  • Topical
  • Other

By Application:

  • Gastroeneterology
  • Respiratory infections market
  • Skin infection treatment
  • Wound prophylaxis
  • Urogenital infection treatment
  • Others

By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape

Inhaled Nitric Oxide Delivery Systems Market Growth : Inhaled Nitric Oxide Delivery Systems worldwide, the market is expected to reach a worth of about US$ 735.7 Mn by the end of 2032, with a projected CAGR of 9.5% during 2022 – 2032.

Hemostatic Gels Market Analysis : The global hemostatic gels market was valued at US$ 957.1 Mn in 2021, and is expected to expand at a CAGR of 6.8% to reach US$ 1.9 Bn by 2032.

Aflatoxicosis Treatment Market Forecast : As per the analysis, the global aflatoxicosis treatment market is expected to secure US$ 403.5 Million from 2022 to 2032, while recording a CAGR of 3.8% during the prior mentioned time period.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs